Apyx Medical CorporationAPYXNASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank79
5Y CAGR+26.6%
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

5Y CAGR
+26.6%/yr
Long-term compound
Percentile
P79
Within normal range
vs 5Y Ago
3.3x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
202551.44%
2024-224.61%
202372.84%
2022-90.57%
202132.89%
202015.82%
20197.48%
2018-393.85%
2017-38.58%
201649.69%